Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results Meeting Abstract
| Authors: | Hamid, O.; Hwu, W. J.; Richards, J. M.; Weber, J. S.; Wolchok, J. D.; Sznol, M.; Minor, D. R.; Pavlick, A. C.; Urba, W. J.; Hodi, F. S.; Yang, A.; Michener, T.; Balogh, A.; McDermott, D. F. |
| Abstract Title: | Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009800027 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.8508 |
| Notes: | Meeting Abstract: 8508 -- Source: Wos |
